Wartapoin
Nutrition

Building a Robust, High-Yield Biologics Manufacturing Platform: An Integrated Development Case Study

Published Oct 13, 2026 Reads 691 By scox

Building a Robust, High-Yield Biologics Manufacturing Platform: An Integrated Development Case Study scox Tue, 10/13/2026 - 15:41 Tue, 11/17/2026 - 09:00 Resource Type Webinar Michał Sobala, PhD Kamil...

Building a Robust, High-Yield Biologics Manufacturing Platform: An Integrated Development Case Study
Building a Robust, High-Yield Biologics Manufacturing Platform: An Integrated Development Case Studyscox
Resource Type

As biologics processes become increasingly productive, higher upstream titers can create new challenges in downstream processing, product quality, scale-up and manufacturing economics. In this webinar, our Process Development, Analytical Development and MS&T experts will present an integrated development case study, demonstrating how cross-functional collaboration supported the evolution from a conventional process toward a robust, high-yield manufacturing-ready platform.

Topics covered:

  • USP intensification and its impact on DSP design and performance
  • Platform analytical strategies supporting process decisions and product quality
  • Scale-up, process robustness and technology transfer considerations
  • Conventional vs. optimized process approaches and key COGS drivers

Why attend?

  • Gain practical insights from an integrated biologics development program
  • See how PD, AD and MS&T expertise can be combined across development and scale-up
  • Learn how to balance yield and productivity with quality, robustness, scalability and manufacturing economics
Logos
Fierce Biotech Mix Logo.png
Attribution
0
0
Attribution
0
Primary Category
On Demand
Off
Enable Automatic On Demand
On
Listing Image
rezonbio_listing_250x190.png
Listing Introduction
In this webinar, our Process Development, Analytical Development and MS&T experts will present an integrated development case study, demonstrating how cross-functional collaboration supported the evolution from a conventional process toward a robust, high-yield manufacturing-ready platform.
On Demand Start Date
End Date/Time
Source: scox · www.fiercepharma.com

Discussion

Sign in to join the discussion.